[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$6share Graphic](https://lunarcrush.com/gi/w:26/t:$6share.png) $6share

$6share sees increased mentions and creator activity, but market volatility remains a concern.

### About $6share
A cryptocurrency project.  

### Insights [#](/topic/$6share/insights)
- $6share mentions hit X which is XXX% higher than it's daily average.
- $6share creators hit X which is XXX% higher than it's daily average.
- $6share Mentions hit a 52-Week high of X for the day
- $6share Mentions hit an all time of X for the day

### Engagements: XXX [#](/topic/$6share/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$6share/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$6share/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXXXX -XX%  
**1 Month**: XXXXX -XX%  
**1-Year High**: XXXXX on 2025-07-14  
**1-Year Low**: X on 2025-05-21  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$6share/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$6share/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$6share/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Month**: X no change  
**1-Year High**: X on 2025-10-15  
**1-Year Low**: X on 2025-05-03  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: X [#](/topic/$6share/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$6share/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$6share/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $6share in the last XX hours which is up XX% from X in the previous XX hours
**Daily Average**: X  
**1 Month**: X no change  
**1-Year High**: X on 2025-08-14  
**1-Year Low**: X on 2025-05-03  

The most influential creators that mention $6share in the last XX hours

| Creator                                    | Rank | Followers | Posts | Engagements |
| -------                                    | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X    | XXXXXX    | X     | XX          |

[View More](/list/creators/$6share/100)
  
  
### Sentiment: XX% [#](/topic/$6share/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$6share/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$6share/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -XX%  
**1-Year High**: XXX% on 2025-07-15  
**1-Year Low**: XX% on 2025-07-24  

**Most Supportive Themes**
- **Community Enthusiasm:** (65%) Positive sentiment regarding project developments and future prospects.
  
**Most Critical Themes**
- **Market Volatility:** (35%)  Concerns about price fluctuations and market uncertainty.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXX      | XX% | XX      | XX% | XX       | XX% |
|         |          |     |         |     |          |     |
| Total   | XXX      | XX% | XX      | XX% | XX       | XX% |
  


**Top assets mentioned**
In the posts about $6share in the last XX hours

[Novo-Nordisk (NVO)](/topic/$nvo)
[Akero Therapeutics, Inc. Common Stock (AKRO)](/topic/akro-akero-therapeutics-inc)
[Akropolis (AKRO)](/topic/$akro)
[Johnson & Johnson (JNJ)](/topic/johnson-johnson)
[Johnson & Johnson (JNJ)](/topic/$jnj)
[Rayonier Inc. (RYN)](/topic/$ryn)
[PotlatchDeltic Corporation Common Stock (PCH)](/topic/$pch)
[DAOLaunch (DAL)](/topic/$dal)
[Delta Air Lines, Inc. (DAL)](/topic/dal-delta-air-lines)

**Top topics mentioned**
In the posts about $6share in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$nvo](/topic/$nvo), [akro akero therapeutics inc](/topic/akro-akero-therapeutics-inc), [$akro](/topic/$akro), [$novcde](/topic/$novcde), [$uxin](/topic/$uxin), [timothy](/topic/timothy), [$52b](/topic/$52b), [$54share](/topic/$54share), [investments](/topic/investments), [$psnl](/topic/$psnl), [johnson johnson](/topic/johnson-johnson), [$jnj](/topic/$jnj), [$ryn](/topic/$ryn), [$pch](/topic/$pch), [jan](/topic/jan), [fell](/topic/fell), [$lux](/topic/$lux), [debt](/topic/debt), [primary market](/topic/primary-market), [lux](/topic/lux), [$dal](/topic/$dal), [dal delta air lines](/topic/dal-delta-air-lines), [coins defi](/topic/coins-defi), [coins dao](/topic/coins-dao), [stocks industrials](/topic/stocks-industrials), [$telo](/topic/$telo), [acquisition](/topic/acquisition), [$ngne](/topic/$ngne), [$cdtx](/topic/$cdtx), [sits](/topic/sits), [$etnb](/topic/$etnb), [marks](/topic/marks)

### Top Social Posts [#](/topic/$6share/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Key moves from todays filings: -Spin-off: $JNJ to separate its Orthopaedics business into standalone DePuy Synthes within 18-24 months -Merger Arb: $RYN/$PCH agree to $8.2B all-stock merger XXXXXX Rayonier shares per PCH share (8.25% premium) -Merger Arb: $AKRO to be acquired by Novo Nordisk for $54/share plus $6/share CVR (total $5.2B) -Allegation: $JEF addressed fraud allegations related to Point Bonita Capitals exposure in First Brands Group -CEO Change: $VMC names Ronnie A. Pruitt next CEO; $PRIM appoints Koti Vadlamudi as CEO Full details in thread below"  
[X Link](https://x.com/catalyst8kio/status/1978390416111345805) [@catalyst8kio](/creator/x/catalyst8kio) 2025-10-15T09:20Z XX followers, XX engagements


"$ETNB competitor developing a MASH treatment $AKRO was just acquired by $NVO. Big pharma is clearly betting heavily on these drugs. Theres also an interesting CVR component attached to the AKRO deal. The offer is for $54/share in cash + $6/share in CVR and the stock currently trades at $54.08/share. The CVR payout is tied to the cirrhosis indication approval as well but with much stronger upside than in the case of ETNB. I havent looked into this in detail yet but its worth checking out"  
[X Link](https://x.com/InvestSpecial/status/1976643630484869147) [@InvestSpecial](/creator/x/InvestSpecial) 2025-10-10T13:39Z 31K followers, 5818 engagements


"📣 Biotech Stock News 10/09 @ Open $TELO XX% Discovery of Telomir-1 in Cancer Cells $AKRO XX% Acquisition for up to $XXX Billion $NGNE XX% Positive Regulatory Update for NGN-401 $CDTX XX% FDA Breakthrough Therapy Designation for CD388 $APGE X% Pricing of $XXX Million Offering $SXTP X% Unveils Chronic Babesiosis Clinical Trial $ANVS X% Novel Biomarker Data in Alzheimer's $WGS X% Launch of Autism Partnership Program $PTHS X% Launches Moms Against Molluscum Movement $ADIL X% Partners for Precision Medicine Testing $CPRX X% Presentations at Upcoming Scientific Conferences $AMIX X% U.S. Patent for"  
[X Link](https://x.com/BiopharmIQ/status/1976314440908931409) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-09T15:50Z 27.4K followers, 9824 engagements


"📢M&A News: Novo Nordisk to acquire Akero Therapeutics for up to $5.2B 🚨 💰 $54/share cash + $6/share CVR tied to FDA approval of efruxifermin for MASH cirrhosis 📈 XX% premium to Akeros pre-deal price 🧬 Adds Phase X FGF21 analog EFX to Novos metabolic portfolio 🗓 Deal closes by YE 2025 pending approvals 🤔 Signals renewed M&A momentum in MASH/NASH. Validates FGF21 pathway.potential re-rating for peers like $VKTX $TERN See image for more details"  
[X Link](https://x.com/BiopharmIQ/status/1976303356961550704) [@BiopharmIQ](/creator/x/BiopharmIQ) 2025-10-09T15:06Z 27.4K followers, 16K engagements